← All candidates
68 insider filings on record.
68 filings on record.
ANABANAPTYSBIO, INC
NasdaqGS · Healthcare · $1.68B
$54.33
-1.50% · Sep 11
68 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 29 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.68B
Float
19.8M
67% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
10.8
Price / sales
7.2
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
63 more transactions on Pro →Context
Wall St
$87.09 avg target
+60.3% vs today · 11 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 3 quarters beat
Q4 '25$1.58 act+$0.65
Q3 '25$0.52 act+$1.77
Q2 '25−$1.34 act+$0.24
Coverage
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?Zacks · 05-21Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?Zacks · 05-19AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks · 05-14Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal OutcomeSimply Wall St. · 05-11
The file stays open
68 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice